# Edoxaban in Peripheral Arterial Disease

> **NCT01802775** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 203 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** edoxaban
- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01802775
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-06
- **Primary completion:** 2014-12-03
- **Final completion:** 2014-12-03
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802775, "Edoxaban in Peripheral Arterial Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01802775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*